Approved Oncology Drugs Set Information: A set of FDA-approved anticancer drugs to enable cancer research.
This plated set (2 microtiter plates/set) contains most current FDA-approved anticancer drugs. The set consists of 88 agents and is intended to enable cancer research, drug discovery and combination drug studies. Details on the drugs included in this plated set can be found by clicking on Approved Oncology Drugs Plated Set ( Plate 1, Plate 2.) Clickable links within the excel files will dynamically query the DTP databases to retrieve up to date DTP information, including NCI60 data, for each drug. Compounds in this set are provided as 20 microliters at 10mM in 100% DMSO; plates are shipped frozen, with dry ice. All proprietary agents in this set were obtained through commercial sources.
To obtain a copy of the Approved Oncology Drugs set, please refer to the procedure for requesting plated samples and use the standard SLA provided.
Some useful links for this set are below
- SDF file with compound structures: FullFDAlist.sdf
- NSC numbers and Chemical Names: FDAPlated_names.txt
- NCI60 screening data: approvedDrugsNCI60.zip
- Open Chemical Repository Collection
- Procedure for Requesting Plated Samples
If you have questions concerning the use of the Approved Oncology Drugs set, please send an e-mail to: ncidtpinfo@mail.nih.gov
Updated: 05/18/09